SCHEMBL8287255

SCHEMBL8287255

CSc1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.39
HPGD P15428 3/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 4/20 0.37
PPARG P37231 2/20 0.37
NCOA2 Q15596 2/20 0.37
NCOA1 Q15788 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE11A Q9HCR9 1/20 0.35
GSK3B P49841 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND2 P30279 1/20 0.34
CCND3 P30281 1/20 0.34
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287266 0.87 GAA (0.35) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL8287214 0.84 GAA (0.44) GAAHPGDMAPK1ALDH1A1NPSR1
SCHEMBL8287246 0.83 GAA (0.39) GAAHPGDMAPK1ALDH1A1NPSR1
SCHEMBL8287501 0.82 GAA (0.39) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL5872272 0.82 GAA (0.38) GAAHPGDMAPK1ALDH1A1NPSR1
SCHEMBL8287281 0.82 GAA (0.38) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL8286454 0.82 GAA (0.38) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL8286488 0.81 GAA (0.39) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL8286163 0.81 BRAF (0.40) GAAHPGDMAPK1ALDH1A1PDE11A
SCHEMBL8287268 0.81 GAA (0.38) GAAHPGDMAPK1ALDH1A1PDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed